REDHILL BIOPHARMA LTD. Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement
REDHILL BIOPHARMA LTD. (RDHL) had Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement of $1.05 as of 2018-12-31, per its 20-F filed 2019-02-26.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement · last filed 2019-02-26
- 2018-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement $1.05.
- 2017-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement $1.05.
- 2016-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement $0.95.
- 2015-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement $0.88.
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement |
|---|---|
| 2018-12-31 | $1.05 20-F · filed 2019-02-26 |
| 2017-12-31 | $1.05 20-F · filed 2019-02-26 |
| 2016-12-31 | $0.95 20-F · filed 2019-02-26 |
| 2015-12-31 | $0.88 20-F · filed 2018-02-22 |